PRA

PRA International Opens Milan Office

Friday, October 30, 2009 07:30 AM

Raleigh, N.C.-based PRA International, a CRO, has opened a new office in Milan, Italy. PRA has operated in Italy since 2003 with home-based PRA staff.

More... »

CenterWatch Monthly May 2009

Friday, May 1, 2009 11:00 AM

U.S. Sites Rate Novo Nordisk, Novartis and Eisai as Top Sponsors in 2009

More... »

PRA Expands Service Offerings in Asia-Pacific

Monday, February 2, 2009 08:00 AM

Recognizing the growing potential for drug development in Southeast Asia, especially Japan, PRA International has entered into a strategic collaboration with two contract research organizations (CROs) in that region.

More... »

PRA International Completes Buyout

Thursday, December 13, 2007 12:58 PM

Genstar Capital, a private equity group based in San Francisco, has completed its acquisition of PRA International, paying $797 million for the Raleigh, N.C.-based contract research organization (CRO).

More... »

A Stock Split Can Make You Forget

Wednesday, February 15, 2006 11:06 AM

PPD's two-for-one stock split is good news for the top global clinical  research organizations. Investors attracted to the sector by the  company's split announcement Feb. 8 can focus on PPD and other top CROs  rather than the sideshow embattled SFBC has become. When new investors look at top CROs such as PPD, Quintiles , PRA, ICON, Parexel and Covance, they will see the pharmaceutical outsourcing industry  ready to consolidate around a handful or so of these companies.These  global CROs have a big advantage over the estimated 1,000 other small  CROs throughout the world. They have international infrastructure in  place to conduct complex clinical trials in thousands of patients at  sites across multiple countries.That global presence is not easy to  build and represents a barrier to entry for small CROs trying to roll  up into a global player.

More... »